is there a shortage of tirzepatide FDA says over after taking second look Tirzepatide Shortage Resolved: What It

A Reuters report 1 noted that Hims & Hers began selling various Eli Lilly drugs on their platformboth branded forms of tirzepatideincluding Zepbound, a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for weight loss, and Mounjaro, which is not approved for weight loss but for the treatment of type 2 diabetes

Mounjaro and Zepbound, both manufactured by Eli Lilly, come as prefilled single-dose pens or single-dose vials

The disadvantage is precision at lower doses

Additionally, some patients who have successfully lost weight on standard doses may consider microdosing GLP-1 as part of a maintenance strategy, particularly if they find that conventional doses continue to impact their weight when theyre ready to stabilize

Important Safety Information READ MORE LESS Scroll to Indication Important Safety Information Do not share your Ozempic pen with other people, even if the needle has been changed